Brian Baranick, General Mgr, Precision Oncology at EXACT SCIENCES CORP (EXAS), sold 984 shares at $47.12 ($46K) on 2022-08-05, disclosed to the SEC on 2022-08-08.
Scheduled sale ($46k) by General Mgr, Precision Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EXAS | SELL | 2024-09-19 | $65K | — | Filing → |
| EXAS | SELL | 2024-05-02 | $7K | — | Filing → |
| EXAS | SELL | 2024-04-03 | $147K | — | Filing → |